Beijing Beilu Pharmaceutical (300016) — Cash Flow Reinvestment Rate
Beijing Beilu Pharmaceutical (300016) has a Cash Flow Reinvestment Rate of 0.78x as of September 2025, reinvesting CN¥57.96 Million (capex CN¥57.96 Million ) from operating cash flow of CN¥74.66 Million. See free cash flow generation of Beijing Beilu Pharmaceutical to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Beijing Beilu Pharmaceutical Cash Flow Reinvestment Rate (2006–2024)
Historical reinvestment intensity for Beijing Beilu Pharmaceutical across 18 annual periods. For the full cash flow conversion analysis, see Beijing Beilu Pharmaceutical (300016) cash conversion ratio.
Annual Cash Flow Reinvestment Rate for Beijing Beilu Pharmaceutical (2006–2024)
Year-by-year capital reinvestment analysis for Beijing Beilu Pharmaceutical. See 300016 financial flexibility index to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.71x | CN¥115.95 Million | CN¥163.02 Million | CN¥101.39 Million | ▼ -83.9% |
| 2023 | 4.43x | CN¥258.93 Million | CN¥58.46 Million | CN¥144.61 Million | ▲ +182.3% |
| 2022 | 1.57x | CN¥200.55 Million | CN¥127.81 Million | CN¥102.78 Million | ▼ -0.8% |
| 2021 | 1.58x | CN¥171.89 Million | CN¥108.73 Million | CN¥147.76 Million | ▲ +55.9% |
| 2020 | 1.01x | CN¥178.50 Million | CN¥176.00 Million | CN¥172.10 Million | ▲ +92.6% |
| 2019 | 0.53x | CN¥82.57 Million | CN¥156.81 Million | CN¥34.99 Million | ▼ -54.0% |
| 2018 | 1.14x | CN¥201.08 Million | CN¥175.75 Million | CN¥54.06 Million | ▲ +58.8% |
| 2017 | 0.72x | CN¥104.44 Million | CN¥144.92 Million | CN¥55.00 Million | ▼ -77.9% |
| 2016 | 3.25x | CN¥247.91 Million | CN¥76.17 Million | CN¥44.21 Million | ▲ +259.3% |
| 2015 | 0.91x | CN¥73.23 Million | CN¥80.85 Million | CN¥69.23 Million | ▼ -11.3% |
| 2014 | 1.02x | CN¥42.99 Million | CN¥42.11 Million | CN¥42.99 Million | ▲ +19.0% |
| 2013 | 0.86x | CN¥35.48 Million | CN¥41.37 Million | CN¥35.48 Million | ▼ -69.1% |
| 2012 | 2.78x | CN¥63.47 Million | CN¥22.86 Million | CN¥63.47 Million | ▲ +298.4% |
| 2011 | 0.70x | CN¥31.87 Million | CN¥45.73 Million | CN¥31.87 Million | ▼ -49.5% |
| 2010 | 1.38x | CN¥51.77 Million | CN¥37.51 Million | CN¥51.77 Million | ▲ +1403.5% |
| 2009 | 0.09x | CN¥5.32 Million | CN¥57.91 Million | CN¥5.32 Million | ▲ +393.1% |
| 2007 | 0.02x | CN¥228.50K | CN¥12.28 Million | CN¥228.50K | ▼ -75.7% |
| 2006 | 0.08x | CN¥1.51 Million | CN¥19.65 Million | CN¥1.51 Million | — |